stimuli includes alterations of cell shape and cell surface antigenicity,l of cell-cell recognition and cellular adhesion,2 of cell matrix binding3 and the adaptation of cell surface receptors. 4 The plasma membrane is therefore regarded as a 'central agency' for the integration of a single cell into the complex system of a tissue or of an organism. The numerous functions of the plasma membrane are mainly mediated by membrane integrated glycoproteins or glycolipids both sharing the common feature of covalently bound oligosaccharide side chains. Specific alterations of oligosaccharide structure and metabolism associated with growth, differentiation and various pathologic conditions suggest a specific role for the oligosaccharide moieties in the regulation of cell surface functions (Table 1) . This review intends to focus on the role of plasma membrane glycoproteins describing briefly principles of glycoprotein structure and function, and characteristics of their biosynthesis and degradation.
Structure of plasma membrane glycoproteins
The polypeptide backbone of plasma membrane glycoproteins is constituted by at least two domains, a sequence rich in hydrophobic amino acids which anchors them to the lipid bilayer, and a hydrophilic domain at the extracellular membrane surface. Several glycoproteins such as the insulin receptor, the EGF receptor or the LDL receptor span the membrane and 18 ) Biantennary oligosaccharides -for example, may form three dimensional structures shaped like a T or Y thus exposing also sugar sequences in an inner position. Formation of three dimensional structures involves mutual interactions with the protein moiety and is therefore subject also to alterations of the amino acid sequence. Moreover, removal of terminal neuraminic acid residues forming non-covalent bonds with basic amino acids of the polypeptide, may modify the conformation of the oligosaccharide. Because glycosidic linkages are partly able to rotate, oligosaccharides of glycoproteins must be regarded as flexible structures.
Functions of plasma membrane glycoproteins
Because of their structural diversity and modifiability 0-and N-linked oligosaccharides of plasma membrane glycoproteins serve as carriers of biological information either modulating the properties of functional glycoproteins or serving as specific signals Figure 2 schematically shows how binding of a complex N-linked oligosaccharide to a galactose specific lectin is controlled by the terminal sugar sequence. Binding to the lectin is initiated by the removal of terminal neuraminic acid which masks the penultimate galactose residue, whereas segregation of the oligosaccharide from the receptor may result from the subsequent removal of the galactose determinant. Desialylation of serum glycoproteins followed by binding and endocytosis by a galactose specific hepatic lectin has been characterised in detail as a major mechanism of the regulation of serum glycoprotein homeostasis. 34 The identification of developmentally regulated lectins which are prominent at a specific stage of development of a tissue,36 and of tumour associated lectins37 indicates that oligosaccharide-lectin interactions participate in embryonic development and in malignant growth. Structural modifications of cell surface oligosaccharides observed in developing5 and neoplastic cells""12 could represent the de novo synthesis of lectin binding sites Second to biosynthesis the concentration of a receptor at the cell surface can also be regulated by interiorisation of the receptor followed by either degradation-" or delivery to an intracellular storage compartment.52 Although the biochemical mechanisms that control receptor down regulation are not yet known, evidence is accumulating that the oligosaccharide moiety has a key role in the regulation of receptor glycoprotein degradation. Lack of N-linked oligosaccharides or 0-linked oligosaccharides causes enhanced degradation of the acetylcholine receptor53 or the LDL receptor,43 respectively. Furthermore, studies in cell mutants suggest that not only deficiency but also structural alterations of N-and 0-linked oligosaccharides may increase receptor breakdown. 44 As oligosaccharides of plasma membrane glyco-proteins are stepwise degraded either in situ at the cell surface or during membrane recycling54-56 alterations of oligosaccharide structures are likely to occur during the life cycle of a receptor glycoprotein. Intact glycosylation may be essential for stabilisation of the receptor molecule against proteolysis (for review see20) or against denaturation in the acidic environment of endosomes, or may be part of an escape mechanism that protects receptors from segregation into the lysosomal compartment. Influencing protein conformation, accessibility of binding sites or the proper exposure of the receptor on the cell surface, structural carbohydrates may also modulate receptor binding affinity.
According to these examples, oligosaccharides of plasma membrane glycoproteins are involved in cell surface functions in at least two different ways: (1) either as effectors -for example, when interacting with sugar specific receptors in cell-cell recognition, or (2) as covalently-bound modulators of activities effected by the polypeptide moiety -for example, in receptors. Both of these mechanisms are subject to structural alterations of the oligosaccharide side chains. In order to avoid uncontrolled structural changes hazardous for cell surface functions, but also to generate specific structures, which may modulate a particular function, oligosaccharides of plasma membrane glycoproteins must be under precise control.
Biosynthesis and degradation of plasma membrane glycoproteins
In contrast with the other polymers of the cell DNA, RNA and proteins, oligosaccharides are not synthesised on a template. Biosynthesis of N-linked oligosaccharides49 starts in the endoplasmic reticulum with the assembly of a common precursor oligosaccharide Glc3Man9(GlcNAc2) linked by pyrophosphate to the lipid carrier dolichol. Catalised by specific glycosyltransferases monosaccharide residues are stepwise transferred to the lipid carrier from either sugar nucleotides or dolichol-linked sugars. The precursor oligosaccharide which contains the common pentasaccharide core of N-linked oligosaccharides is highly conserved in evolution and found in nearly all eukaryotes. After en bloc transfer to asparaginyl residues that are part of a Asn-X-Ser/ Thr sequence, the precursor oligosaccharide is extensively processed to yield the different mature structure. Processing starts with the stepwise removal of the three terminal glucose residues catalysed by two specific glucosidases, and of up to four mannose residues by mannosidases of the endoplasmic reticulum and the cis cisternae of the Golgi apparatus to yield high mannose oligosaccharides. Intermediates destined to become complex type structures are further processed by addition of a N-aceytlglucosamine residue by N-acetylglucosaminyltransferase I followed by removal of two mannose residues by Golgi mannosidase II. Thereafter peripheral sugars are stepwise transferred from sugar nucleotides to the trimmed oligosaccharide in the medial and trans cisternae of the Golgi apparatus before insertion into the plasma membrane. Unlike the assembly of the lipid linked precursor which seems to proceed via a single pathway in most cells, processing of oligosaccharides is tremendously diverse and allows to generate a great variety of oligosaccharide structures.
Whereas the sequence of processing events is fairly well understood, little is known about the control mechanisms that direct the formation of particular structures. Several factors that may control processing have been proposed (Table 4) . Whereas the conformation of the polypeptide backbone57 and its insertion into the membrane bilayer58 represent determinants which reside in the glycoprotein itself, the concentration of sugar nucleotides and dolicholphosphate,59 and the level of expression of the various glycosidases and glycosyltransferases may be influenced by endogenous and exogenous stimuli and may reflect conditions at the time of synthesis.
Modifications of oligosaccharides presumedly are not restricted to the biosynthetic pathway, but also seem to occur after insertion of glycoproteins into the plasma membrane. Terminal sugar residues L-fucose and N-acetylneuraminic acid of plasma membrane glycoproteins are rapidly removed from the glycoproteins two to four times faster compared to the half-life of the polypeptide backbone.654560 Loss of terminal sugars occurs either in situ in the plasma membrane or in endocytotic compartments during membrane recycling.58 Core sugars are removed in the different glycoproteins with individual half-lives in between that of the polypeptide and that of core sugars.54 55 61 This indicates that the oligosaccharides of plasma membrane glycoproteins may be trimmed to an individual extent by limited deglycosylation. Knowledge of the pathways and the regulation of oligosaccharide biosynthesis and degradation will not only further the discovery of diseases that result from defects in glycoprotein metabolism, but will also provide new therapeutic approaches for treating them.
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